Skip to content

Effect of Bioptron Light Therapy on Wound Healing After Caesarean Section

Effect of Bioptron Light Therapy on Wound Healing After Caesarean Section

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07693478
Enrollment
30
Registered
2026-07-09
Start date
2026-07-12
Completion date
2026-08-31
Last updated
2026-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section; Complications, Wound, Dehiscence

Brief summary

The purpose of this study is to investigate the effect of Bioptron light therapy on wound healing after caesarean section.

Detailed description

Wound healing process is important after cesarean section without complication and with short period of time; caesarean section (CS) wound complications represent a substantial burden to the health system and the prevention of such complications should be a healthcare priority in developing countries. Delayed wound healing is when a wound takes longer than normal to heal, it has many hazards such as disruption and fluid collection (hematomas and seromas), adhesions, infection (abscess) and rupture of membranes. Management and acceleration of wound healing after cesarean section are important for maternal and newborn care and breastfeeding. Many drugs used for this purpose, especially nonsteroidal anti-inflammatory drugs (NSAIDs) and opiates, have side effects including nausea, respiratory distress, gastrointestinal bleeding and itching. Previous studies indicated using Bioptron light therapy to accelerate wound healing, it can be used as mono therapy. or as complementary therapy for wound healing and treating pain, Also, it can improve microcirculation, harmonize metabolic processes, reinforce the human defense system, stimulate regenerative processes of the entire organism, promote wound healing and relieve pain. As a non-invasive intervention for wound healing, it enhances the whole individual's regenerative and reparative processes, promote wound healing, regulates vascular endothelial growth factor (VEGF). It also provides faster wound closure, enhanced wound epithelialization and greater scar tensile strength. To our knowledge, there were few previous studies investigated and confirm the effect of Bioptron light therapy on wound healing in patients with diabetic wound and burn wound. But until now there is no previous study investigates its effect on post cesarean section wound healing. so, this study will be the first one in this issue. Therefore, the results obtained from this study will be of valuable benefits for medical service organizations and increase body of knowledge of physical therapists in scientific field.

Interventions

DRUGStandard Postoperative Medical Care

Standard postoperative medical care consisting of analgesics, antibiotics, antiseptics, and anti-inflammatory medications prescribed by the treating obstetrician.

Polarized polychromatic non-coherent light therapy (480-3400 nm, energy density 2.4 J/cm², power density 40 mW/cm², 15 minutes per session, once daily for 5 consecutive days), initiated within the first 24 hours after cesarean section.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 30 Years
Healthy volunteers
No

Inclusion criteria

* Post partum women delivered by cesarean section on their first 24 hours after operation. * Their ages range from 25 to 30 years old. * Their BMI will be less than 30 kg/m2. * All females will be clinically diagnosed, confirmed and referred by the obstetricians. * They are medically stable.

Exclusion criteria

* History of any radiotherapy or chemotherapy. * History of diabetes. * History of psychological problems. * Acute infection in area treated. * Skin disease or any disease leading to delayed wound healing, such as venous or arterial disease.

Design outcomes

Primary

MeasureTime frameDescription
Wound surface area5 daysThe wound surface area (cm²) will be measured by ultrasonography using the wound length × width method. Ultrasound imaging will be performed using a 2.8-10 MHz transducer to objectively assess wound healing. A reduction in wound surface area indicates improved wound healing.

Secondary

MeasureTime frameDescription
Wound healing (REEDA score)5 daysWound healing will be evaluated using the REEDA scale, which assesses five clinical parameters: Redness, Edema, Ecchymosis, Discharge, and Approximation. Each parameter is scored from 0 to 3, yielding a total score ranging from 0 to 15, with lower scores indicating better wound healing.
Wound healing questionnaire (WHQ) score5 daysWound healing will be assessed using the validated Bluebelle Wound Healing Questionnaire (WHQ), which evaluates wound-related signs, symptoms, and wound care interventions following abdominal surgery. Higher total scores indicate greater wound-related problems and delayed healing.

Countries

Egypt

Contacts

CONTACTGhada Hamdy Abd Elmoamen, B.Sc
dodoh2034@gmail.com+20 10 60132861
CONTACTManal Ahmed El Shafei, PhD
STUDY_CHAIRHala Mohamed Omara, PhD

Professor, Cairo University

STUDY_DIRECTORManal Ahmed El Shafei, PhD

Assist Professor, Cairo University

STUDY_DIRECTORSameh Hussien Samir, PhD

Professor, National Research Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 10, 2026